Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility: Report and Recommendation of the President

Reports and Recommendations of the President | June 2021

The project will provide immediate and flexible financing to support the national coronavirus disease (COVID-19) vaccination program through APVAX and from the regular country allocation. The APVAX allocation comprises a rapid response component (RRC) to support the purchase of Asian Development Bank (ADB) eligible COVID-19 vaccines, while the project investment component (PIC) financed by the regular country allocation will support strengthening of the vaccination information dissemination and monitoring systems, vaccine transportation capacity, and vaccine-related medical waste management.

The report and recommendation of the President to the Board of Directors (RRP) document describes the terms and conditions of a project for consideration and approval by ADB's Board of Directors.

This document dated June 2021 is provided for the ADB project 55085-001 in Sri Lanka.

Project Number